Rights and permissions
About this article
Cite this article
Enrolment begins for rifaximin in IBS studies. Inpharma Wkly. 1646, 12 (2008). https://doi.org/10.2165/00128413-200816460-00030
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816460-00030